aortic-valve

A second Vytorin study testing the drug's effectiveness in aortic stenosis showed Vytorin worthless in preventing aortic-valve and cardiovascular events but with a macabre dividend: it increased the chances of getting and dying from cancer.

A Merger From The Folks Who Brought You Vytorin 2009

Dr. Martin expects the registry will eventually enable doctors to see whether surgery or less-invasive catheter-based procedures achieve better results for a variety of heart defects, including the aortic-valve malformation that Matthew Emmerling had.

Little Hearts, Big Problems 2009

Preliminary research by Dr. Maurice Sarano, a Mayo Clinic cardiologist, suggests that statins could be a new treatment for aortic-valve disease.

Mail Call: Evaluating Statins 2007

Doctors agreed Justin's situation was critical, and within a week of his diagnosis, he underwent enormously risky surgery for an aortic-valve replacement.

My Lunch with Harvey Fairstein, Linda 2007

Doctors agreed Justin's situation was critical, and within a week of his diagnosis, he underwent enormously risky surgery for an aortic-valve replacement.

My Lunch with Harvey Fairstein, Linda 2007

Statins also show potential for protecting against aortic-valve disease, a hardening of the valve between the heart and the aorta, and osteoporosis, the age-related deterioration of bone that leads to fractures.

You Want Statins With That? 2007

A second Vytorin study testing the drug's effectiveness in aortic stenosis showed Vytorin worthless in preventing aortic-valve and cardiovascular events but with a macabre dividend: it increased the chances of getting and dying from cancer.

Dissident Voice 2009

A second Vytorin study testing the drug's effectiveness in aortic stenosis showed Vytorin worthless in preventing aortic-valve and cardiovascular events but with a macabre dividend: it increased the chances of getting and dying from cancer.

Dissident Voice 2009

In their article on intensive lipid lowering, Rossebø et al. (Sept. 25 issue) 1 report that therapy with simvastatin and ezetimibe did not reduce aortic-valve disease and calcifications in patients with mild-to-moderate asymptomatic aortic stenosis.

Medlogs - Recent stories 2009

In their article on intensive lipid lowering, Rossebø et al. (Sept. 25 issue) 1 report that therapy with simvastatin and ezetimibe did not reduce aortic-valve disease and calcifications in patients with mild-to-moderate asymptomatic aortic stenosis.

Medlogs - Recent stories 2009